Envision Healthcare (EVHC) Rating Lowered to Hold at ValuEngine

ValuEngine downgraded shares of Envision Healthcare (NYSE:EVHC) from a buy rating to a hold rating in a research report sent to investors on Friday morning.

EVHC has been the topic of a number of other research reports. Citigroup lowered Envision Healthcare from a buy rating to a neutral rating and set a $31.00 target price on the stock. in a research note on Thursday, November 2nd. Mizuho set a $35.00 target price on Envision Healthcare and gave the stock a hold rating in a research note on Wednesday, January 24th. Bank of America reduced their target price on Envision Healthcare from $72.00 to $60.00 and set a buy rating on the stock in a research note on Monday, October 9th. Piper Jaffray Companies assumed coverage on Envision Healthcare in a research note on Wednesday, December 13th. They issued a neutral rating and a $35.00 target price on the stock. Finally, KeyCorp reduced their target price on Envision Healthcare from $67.00 to $37.00 and set an overweight rating on the stock in a research note on Thursday, November 2nd. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company has an average rating of Hold and a consensus price target of $41.50.

Shares of Envision Healthcare (NYSE:EVHC) opened at $33.78 on Friday. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00. Envision Healthcare has a 52 week low of $23.77 and a 52 week high of $73.00. The firm has a market capitalization of $4,230.00, a price-to-earnings ratio of -22.67, a price-to-earnings-growth ratio of 0.91 and a beta of 0.57.

Institutional investors have recently made changes to their positions in the company. CIBC World Markets Inc. purchased a new position in shares of Envision Healthcare during the fourth quarter valued at $208,000. Palisade Capital Management LLC NJ purchased a new position in Envision Healthcare in the third quarter valued at about $229,000. CENTRAL TRUST Co grew its stake in Envision Healthcare by 79.7% in the fourth quarter. CENTRAL TRUST Co now owns 6,626 shares of the company’s stock valued at $229,000 after purchasing an additional 2,939 shares during the last quarter. Alps Advisors Inc. purchased a new position in Envision Healthcare in the fourth quarter valued at about $235,000. Finally, Parametrica Management Ltd purchased a new position in Envision Healthcare in the fourth quarter valued at about $236,000.

COPYRIGHT VIOLATION NOTICE: This report was published by Stock Observer and is the sole property of of Stock Observer. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://www.thestockobserver.com/2018/02/06/envision-healthcare-evhc-rating-lowered-to-hold-at-valuengine.html.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply